⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Motilal Oswal Contra Fund - Growth - Direct Plan | Kotak Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | — | Kotak MF |
| Category | Equity - Contra Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹10.21 (30 Oct 2026) | ₹17.44 (30 Oct 2026) |
| Rating | ★★★ | ★★★ |
| Benchmark | NIFTY 500 - TRI | Nifty Healthcare Index - TRI |
| Fund Manager | Bhalchandra Shinde | Dhananjay Tikariha |
| Inception | 29 May 2026 | 11 Dec 2023 |
| Returns | ||
| 1Y | — | 23.31% |
| 3Y | — | — |
| 5Y | — | — |
| Since Inception | 2.10% | 21.25% |
| Risk | ||
| 9.70 | 14.88 | |
| 0.60 | 0.99 | |
| 0.46 | 1.02 | |
| 10.94 | 3.82 | |
| 0.89 | 2.12 | |
| -5.44% | -11.03% | |
| Costs | ||
| Expense Ratio | 2.27% | 1.04% |
| Exit Load | 1% on or before 365D, Nil after 365D | 0.50% on or before 30D, Nil after 30D |
| Min SIP | ₹500 | ₹100 |
| Min Lumpsum | ₹500 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Motilal Oswal…87%
Kotak MF87%
12.7%Only 12.7% of holdings by weight are common between Motilal Oswal Contra Fund - Growth - Direct Plan and Kotak MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingMotilal Oswal Contra Fund - Growth - Direct PlanKotak MF
Divi's Laboratories Ltd.4.65%9.35%
Triparty Repo5.99%3.01%
Mankind Pharma Ltd.2.57%2.73%
Torrent Pharmaceuticals Ltd.2.46%4.65%
Category context: Equity vs Equity. Open the full Screener →